J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):301-308. doi: 10.1016/j.japh.2022.11.009. Epub 2022 Nov 30.
Since the mid-1990s, more than 500,000 deaths have been attributed to the opioid overdose epidemic, which has created a serious national crisis affecting public health and social and economic welfare. To mitigate these opioid-related overdoses and deaths, interventions targeted at both the patient and community level are needed.
This demonstration project sought to determine whether implementation of a provider-to-provider opioid pain teleconsultation service with a pain specialist was correlated with a reduction in inappropriate opioid use and improve health outcomes.
Individual-level claims data for Health First Colorado Medicaid members were collected between March 1, 2017, and September 30, 2021, for individuals who triggered a provider-to-provider pain management teleconsultation based on receipt of a prescription for an opioid where the member was receiving a high-dose opioid (n = 125) or was opioid-naive (n = 819). The primary outcome measures were a patient's opioid dose less than 200 morphine milligram equivalent (MME) by 6 months after the consult if consult was triggered for high-dose use or discontinuation of an opioid by 12 weeks after consult if the consult was triggered for opioid naivety. Secondary opioid-related health outcomes were also assessed.
In the high-dose opioid cohort, 87% of the members had their monthly average MME reduced to less than 200 by 180 days after their consult. More than half of the opioid-naive group had discontinued their opioid by 90 days after their consult.
Results indicate that provider-to-provider teleconsultation services with a pain specialist can be an effective intervention at reducing total inappropriate opioid use.
自 20 世纪 90 年代中期以来,已有超过 50 万人死于阿片类药物过量流行,这造成了严重的全国性危机,影响了公共卫生和社会经济福利。为了减轻这些与阿片类药物相关的过量用药和死亡,需要针对患者和社区层面采取干预措施。
本示范项目旨在确定是否实施医疗保健提供者之间的阿片类药物疼痛电话咨询服务与疼痛专家相关联,是否可以减少不适当的阿片类药物使用并改善健康结果。
在 2017 年 3 月 1 日至 2021 年 9 月 30 日期间,收集了科罗拉多健康第一 Medicaid 会员的个人层面索赔数据,这些数据是基于接受阿片类药物处方触发医疗保健提供者之间的疼痛管理电话咨询的个人,这些个人正在接受高剂量阿片类药物(n=125)或阿片类药物无经验(n=819)。主要结果测量指标是在咨询后 6 个月内,咨询是为高剂量使用而触发的患者的阿片类药物剂量低于 200 吗啡毫克当量(MME),如果咨询是为阿片类药物无经验而触发的,则在咨询后 12 周内停止使用阿片类药物。还评估了次要的与阿片类药物相关的健康结果。
在高剂量阿片类药物队列中,87%的患者在咨询后 180 天内将其每月平均 MME 减少到 200 以下。超过一半的阿片类药物无经验组在咨询后 90 天内停止使用阿片类药物。
结果表明,与疼痛专家进行医疗保健提供者之间的电话咨询服务可以有效减少总不适当的阿片类药物使用。